Department of Gastroenterology, The First Affiliated Hospital, Sun Yat-Sen University, No. 58 Zhongshan Road II, Guangzhou, 510080, Guangdong Province, People's Republic of China.
Dig Dis Sci. 2024 Oct;69(10):3901-3910. doi: 10.1007/s10620-024-08582-8. Epub 2024 Aug 6.
Endoscopy-based scoring systems, including Mayo Endoscopic Score (MES), Modified Mayo Endoscopic Score (MMES), and Degree of Ulcerative Colitis Burden of Luminal Inflammation (DUBLIN) Score, have been introduced to evaluate UC prognosis. This study aims to compare their predictive capacity for clinical outcomes in UC patients.
Consecutive UC patients from a tertiary hospital were included. The primary outcome was acute severe ulcerative colitis (ASUC), and secondary outcomes were UC-related admission, medication treatment escalation, disease extension and surgery. Predictive performance was assessed using receiver operating characteristic (ROC) curves.
Among 300 patients, 15.3% developed ASUC. Robust correlations were observed among the three scoring systems and were with elevated serum inflammatory markers. The DUBLIN score exhibited superior predictive ability for UC-related admission (AUC 0.751; 95%CI 0.698-0.799) and medication treatment escalation (AUC 0.735; 95% CI 0.681-0.784). No statistical differences were found among three scoring systems for predicting ASUC, disease extension, and surgery. Employing respective cut-offs of 2, 11.25, and 3, higher MES (HR = 3.859, 95% CI 1.636-9.107, p = 0.002), MMES (HR = 3.352, 95% CI 1.879-5.980, p < 0.001), and DUBLIN score (HR = 5.619, 95% CI 2.378-13.277, p < 0.001) were associated with an increased risk of developing ASUC.
The DUBLIN score, assessing the overall inflammatory burden of the intestinal tract, outperforms the MMES in predicting admission and medication treatment escalation related to UC. Its integration into clinical practice has the potential to enhance risk stratification for patients with UC.
内镜评分系统,包括 Mayo 内镜评分(MES)、改良 Mayo 内镜评分(MMES)和溃疡性结肠炎肠道炎症负担程度(DUBLIN)评分,已被引入用于评估 UC 的预后。本研究旨在比较它们在 UC 患者临床结局预测方面的能力。
纳入一家三级医院的连续 UC 患者。主要结局是急性重度溃疡性结肠炎(ASUC),次要结局是 UC 相关住院、药物治疗升级、疾病扩展和手术。采用受试者工作特征(ROC)曲线评估预测性能。
在 300 例患者中,15.3%发生 ASUC。三种评分系统之间存在稳健的相关性,并与升高的血清炎症标志物相关。DUBLIN 评分在预测 UC 相关住院(AUC 0.751;95%CI 0.698-0.799)和药物治疗升级(AUC 0.735;95%CI 0.681-0.784)方面具有更好的预测能力。三种评分系统在预测 ASUC、疾病扩展和手术方面没有统计学差异。采用各自的截断值 2、11.25 和 3,较高的 MES(HR=3.859,95%CI 1.636-9.107,p=0.002)、MMES(HR=3.352,95%CI 1.879-5.980,p<0.001)和 DUBLIN 评分(HR=5.619,95%CI 2.378-13.277,p<0.001)与发生 ASUC 的风险增加相关。
DUBLIN 评分评估肠道整体炎症负担,在预测 UC 相关住院和药物治疗升级方面优于 MMES。将其纳入临床实践有潜力增强 UC 患者的风险分层。